Munich, January 12, 2024 –Will we all remember 2024 as the year that AI became mainstream?
Prof. Torsten Haferlach and Sebastian Kuss, Co-Founder & Managing Partner at EMH, discussed the topic of “Fighting cancer with AI” in a joint panel at DLD24 in Munich.
Prof. Haferlach, Co-Founder and Managing Director at MLL, is a hematologist and a proven expert in leukemia diagnostics and therapy. He has dedicated himself to the fight against cancer for 40+ years.
According to Prof. Haferlach “AI is not a gadget, but a game changer” in the realm of new diagnostic possibilities. Data saves lives, enabling speedy, yet better quality in diagnostics and thus patient-centered care.
-→ Follow the link to watch the recording of the panel: